Abbott Laboratories

ABT | NYSE

Price Alert Chart Builder DCF Calculator

$102.80

+$0.19 (+0.19%)

Sep 21, 2026, 11:22 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	44.33B	41.95B	40.11B	43.65B	43.08B	34.61B
Cost of Revenue	19.72B	20.63B	20.07B	21.33B	19.86B	17.23B
Gross Profit	24.61B	21.33B	20.04B	22.32B	23.21B	17.38B
Operating Income	8.05B	6.83B	6.44B	8.36B	9.2B	5.29B
Interest Income	230M	344M	385M	183M	43M	46M
Pretax Income	8.47B	7.01B	6.66B	8.31B	8.21B	4.97B
Net Income	6.52B	13.4B	5.72B	6.93B	7.07B	4.5B
Selling & General & Admin	12.38B	11.65B	10.88B	11.11B	11.28B	9.67B
Research & Development	2.96B	2.82B	2.72B	2.85B	2.74B	2.42B
Other Expenses	1.25B	n/a	n/a	n/a	n/a	n/a
Operating Expenses	16.59B	14.47B	13.6B	13.96B	14.01B	12.09B
Interest Expense	341M	603M	698M	315M	410M	708M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	36.28B	35.1B	33.67B	35.29B	33.88B	29.32B
Income Tax Expense	1.94B	-6.39B	941M	1.37B	1.14B	497M
Shares Outstanding (Basic)	1.75B	1.73B	1.73B	1.75B	1.78B	1.77B
Shares Outstanding (Diluted)	1.75B	1.75B	1.75B	1.76B	1.79B	1.79B
EPS (Basic)	3.74	7.67	3.30	3.94	3.97	2.52
EPS (Diluted)	3.72	7.64	3.27	3.91	3.94	2.50
EBITDA	11.55B	10.83B	10.61B	11.89B	12.16B	9B
EBIT	8.81B	7.62B	7.36B	8.62B	8.62B	5.68B
Depreciation & Amortization	2.75B	3.22B	3.24B	3.27B	3.54B	3.33B